Literature DB >> 31726809

MiR-647 promotes cisplatin-induced cell apoptosis via downregulating IGF2 in non-small cell lung cancer.

Wei Jiang1, Xuequn Zhao1, Wenjie Yang2.   

Abstract

Entities:  

Year:  2019        PMID： 31726809     DOI： 10.23736/S0026-4806.19.06240-2

Source DB:  PubMed          Journal:  Minerva Med        ISSN： 0026-4806            Impact factor:   4.806


× No keyword cloud information.
  7 in total

1.  ZFAS1 Exerts an Oncogenic Role via Suppressing miR-647 in an m6A-Dependent Manner in Cervical Cancer.

Authors:  Zhijuan Yang; Jingwen Ma; Shuxia Han; Xiaowen Li; Hua Guo; Dongtao Liu
Journal:  Onco Targets Ther       Date:  2020-11-17       Impact factor: 4.147

2.  Knockdown of miR-183 Enhances the Cisplatin-Induced Apoptosis in Esophageal Cancer Through Increase of FOXO1 Expression.

Authors:  Hao Chen; Bin Zheng; Songtao Xue; Chun Chen
Journal:  Onco Targets Ther       Date:  2020-08-24       Impact factor: 4.147

3.  Identification of a circRNA-miRNA-mRNA regulatory network for exploring novel therapeutic options for glioma.

Authors:  Yi He; Yihong Chen; Yuxin Tong; Wenyong Long; Qing Liu
Journal:  PeerJ       Date:  2021-08-06       Impact factor: 2.984

4.  miR-647 inhibits hepatocellular carcinoma cell progression by targeting protein tyrosine phosphatase receptor type F.

Authors:  Xiangyang Ye; Rongxian Qiu; Xiongzhi He; Zhengting Hu; Fengfeng Zheng; Xiaogang Huang; Xuemei Xie; Feihua Chen; Hangbing Ou; Guoxian Lin
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

Review 5.  MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin.

Authors:  Maria Konoshenko; Yuriy Lansukhay; Sergey Krasilnikov; Pavel Laktionov
Journal:  Int J Mol Sci       Date:  2022-07-08       Impact factor: 6.208

6.  PEGylated Cisplatin Nanoparticles for Treating Colorectal Cancer in a pH-Responsive Manner.

Authors:  Wei Li; Yongjun Sun; Jian Chen; Zhibin Jiang; Jinbao Yang
Journal:  J Immunol Res       Date:  2022-08-05       Impact factor: 4.493

7.  miR-657 Targets SRCIN1 via the Slug Pathway to Promote NSCLC Tumor Growth and EMT Induction.

Authors:  Yingqian Zhang; Jiao Yuan; Mengfei Guo; Run Xiang; Xiang Wang; Tianpeng Xie; Xiang Zhuang; Qiang Li; Qi Lai
Journal:  Dis Markers       Date:  2022-08-17       Impact factor: 3.464
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.